QA: Celgene CORP DE in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2012_Celgene_CORP_DE.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 4,353,225,000
1 IntangibleAssetsNetIncludingGoodwill 4,731,918,000
2 PropertyPlantAndEquipmentNet 506,042,000
3 remainder_Assets 414,725,000
4 LiabilitiesCurrent 1,539,972,000
5 LiabilitiesNoncurrent 273,516,000
6 remainder_Liabilities 2,679,695,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,226,314,000
9 ResearchAndDevelopmentExpense 1,600,264,000
10 remainder_Expenses 717,542,000
11 remainder_Revenues 4,842,070,000
12 remainder_NetIncome 19,506,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,005,910,000
1 Liabilities 4,493,183,000
2 Expenses 3,544,120,000
3 Revenues 4,842,070,000
4 StockholdersEquity 5,512,727,000
5 NetIncome 1,317,456,000
6 ComprehensiveNetIncome 1,317,456,000
7 BaseVar 11,452,394,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.84
9 EconomicCapitalRatio 2.92

Edgar->Model Mapping

Feature Distribution